Pediatric Liver Tumors | Agenda Bookshop Skip to content
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Arthur Zimmermann
B01=Giorgio Perilongo
B19=Dietrich Schweinitz
B19=Marcio Malogolowkin
Category1=Non-Fiction
Category=MJCL
Category=MJJ
Category=MJW
COP=Germany
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€50 to €100
PS=Active
softlaunch

Pediatric Liver Tumors

English

The field of liver tumors in children has seen tremendous therapeutic advances over recent years. This has been achieved through a much better understanding of the biology of disease, improved diagnostic procedures, refined methods of pretreatment tumor staging, the implementation of highly efficient chemotherapy and surgery, detailed monitoring of toxicity, and careful follow-up strategies. International controlled trials have played a key role in these advances, and many leading figures in the trials are among the editors and authors of this book. Their principal goal in Hepatic Tumors in Children is to provide the reader with a complete update on this complex and rapidly evolving field. All aspects of an impressive success story are covered, disclosing how the outcome of a previously devastating disease has been so dramatically improved. This book will prove essential reading for all who are involved in the care of children with liver tumors. See more
Current price €97.84
Original price €102.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Arthur ZimmermannB01=Giorgio PerilongoB19=Dietrich SchweinitzB19=Marcio MalogolowkinCategory1=Non-FictionCategory=MJCLCategory=MJJCategory=MJWCOP=GermanyDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€50 to €100PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Dimensions: 193 x 260mm
  • Publication Date: 21 Dec 2010
  • Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
  • Publication City/Country: Germany
  • Language: English
  • ISBN13: 9783642145032

About

Prof.Dr.med.em Arthur Zimmermann graduated in Medicine at the University of Berne Switzerland. He attended the local Pathology Residency Program followed by several years of experipmental basic research in the fields of cancer cell cycle mutants and mechanisms of leukocyte and cancer cell motility. As chief of staff and then head of the division of surgical pathology at the University of Berne he specialized in hepatobiliary and pancreatic tumor pathology where he became the author and coauthor of more than 500 publications. Until July 2009 Prof. Zimmermann was Acting Director of the Institute of Pathology of the University of Berne. As an expert in pediatric liver tumors he is an international consultant and holds the Pathology Review Center for the International Childhood Liver Tumor Study Group ( SIOPEL ). Prof. Giorgio Perilongo graduated in Medicine in 1980 at the University of Padua Italy; he then attended the local Pediatric Residency program for then completing his post-graduate education with a fellowship in Hematology-Oncology first and in Neuro-Oncology thereafter at the Childrens Hospital of Philadelphia. Presently he is the Chairman of the Department of Pediatrics of the University Hospital in Padua. He was among the founders of the International Childhood Liver Tumor Study Groups (otherwise known as SIOPEL group) the international cooperative research group on childhood liver tumors based in Europe conceived within the umbrella of the International Society of Pediatric Oncology. Within this group is has and he is still playing a very active role. He chaired a series of clinical trials already published in the main international scientific journals.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept